Latest Breaking News On - Japanese diabetes society - Page 1 : comparemela.com

Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update

LYON, France, September 26, 2023 Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its financial results for the period ended June 30, 2023 and provided a corporate update.

France generalNew yorkUnited statesKhoso baluchMerck seronoSumitomo pharmaManavarere arthur rouillThomas kuhnSophie bozecNicolas fossiezFinancial pressEuropean patent officeCommunity weekendInternational meetingAlex leukodystrophy charityMeeting of the japanese diabetes society

Poxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update

Poxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalSophie bozecSumitomo pharmaThomas kuhnNicolas fossiezMerck seronoKhoso baluchManavarere arthur rouillEuropean patent officeMeeting of the japanese diabetes societyAlex leukodystrophy charityCompany universal registration documentUs patent officeFinancial pressUnited leukodystrophy foundation scientific symposium

Poxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update

Poxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesManavarere arthur rouillNicolas fossiezSumitomo pharmaMerck seronoSophie bozecKhoso baluchThomas kuhnUs patent officeCompany universal registration documentCommunity weekendUnited leukodystrophy foundation scientific symposiumEuropean patent officeAlex leukodystrophy charityMeeting of the japanese diabetes society

Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update

Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNicolas fossiezSumitomo pharmaMerck seronoRichard kenderPascale boisselThomas kuhnNoah beermanArthur rouillDavid mollerMeeting of the japanese diabetes societyFinancial pressBusiness developmentKidney internationalEuropean commissionDrug administration

Poxel Announces TWYMEEG (Imeglimin) Fiscal Year 2022 Sales

TWYMEEG sales in Japan for Sumitomo Pharma Fiscal Year 20221 reached JPY 2.2 billion2 (EUR 15.0 million)3, exceeding guidance4 by more than 20% TWYMEEG's Fiscal Year 20235 forecast of JPY

United statesSumitomo pharmaArthur rouillNicolas fossiezThomas kuhnMerck seronoMeeting of the japanese diabetes societySumitomo pharma fiscal yearFiscal yearChief executive officerImeglimin phaseAnnual meetingJapanese diabetes societyEuronext parisRelations communication senior directorVice president